Comparisons of efficacy and safety in insulin glargine and lixisenatide plus glulisine combination therapy with multiple daily injection therapy in Japanese patients with type  2 diabetes

ConclusionsiGlarLixi  + insulin glulisine combination therapy is safe and equally efficacious as multiple daily injection therapy for glycemic control, while avoiding hypoglycemia risk and reducing the number of injections are required.

Source: Journal of Diabetes Investigation - October 11, 2021 Category: Endocrinology Authors: Yuji Kawaguchi, Shoko Miyamoto, Yuriko Hajika, Narumi Ashida, Koji Masumoto, Jun Sawa, Kenji Hamazaki, Yasuro Kumeda Tags: Original Article Source Type: research